25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Lipum AB
Buy, Hold or Sell?

Let's analyze Lipum together

I guess you are interested in Lipum AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lipum AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Lipum AB

I send you an email if I find something interesting about Lipum AB.

1. Quick Overview

1.1. Quick analysis of Lipum (30 sec.)










1.2. What can you expect buying and holding a share of Lipum? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr2.33
Expected worth in 1 year
kr4.33
How sure are you?
31.3%

+ What do you gain per year?

Total Gains per Share
kr2.00
Return On Investment
14.6%

For what price can you sell your share?

Current Price per Share
kr13.70
Expected price per share
kr11.30 - kr14.25
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lipum (5 min.)




Live pricePrice per Share (EOD)
kr13.70
Intrinsic Value Per Share
kr-111.70 - kr-133.40
Total Value Per Share
kr-109.37 - kr-131.07

2.2. Growth of Lipum (5 min.)




Is Lipum growing?

Current yearPrevious yearGrowGrow %
How rich?$4.7m$1.4m$108.3k7.1%

How much money is Lipum making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$1m772.000.1%
Net Profit Margin-5,893.9%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Lipum (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#696 / 960

Most Revenue
#760 / 960

Most Profit
#240 / 960

Most Efficient
#850 / 960
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lipum?

Welcome investor! Lipum's management wants to use your money to grow the business. In return you get a share of Lipum.

First you should know what it really means to hold a share of Lipum. And how you can make/lose money.

Speculation

The Price per Share of Lipum is kr13.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lipum.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lipum, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr2.33. Based on the TTM, the Book Value Change Per Share is kr0.50 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lipum.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.09-0.6%-0.05-0.4%-0.06-0.4%-0.05-0.4%-0.05-0.4%
Usd Book Value Change Per Share0.251.8%0.050.4%-0.010.0%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.251.8%0.050.4%-0.010.0%0.010.1%0.010.1%
Usd Price Per Share0.79-0.74-1.21-1.03-1.03-
Price to Earnings Ratio-2.31--4.30--5.38--5.90--5.90-
Price-to-Total Gains Ratio3.21-0.16--17.67--18.85--18.85-
Price to Book Ratio3.52-4.38-39.86-15.28-15.28-
Price-to-Total Gains Ratio3.21-0.16--17.67--18.85--18.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.32205
Number of shares756
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (756 shares)36.5410.62
Gains per Year (756 shares)146.1842.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1014613604232
2029228208574
304394280127116
405855740170158
507317200212200
608778660255242
70102310120297284
80116911580340326
90131613040382368
100146214500425410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.015.00.06.3%1.015.00.06.3%1.015.00.06.3%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.011.00.031.3%5.011.00.031.3%5.011.00.031.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.016.00.0%0.00.016.00.0%0.00.016.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.011.00.031.3%5.011.00.031.3%5.011.00.031.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Lipum AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.5540.501+410%-0.070+103%0.146+1653%0.146+1653%
Book Value Per Share--2.3300.746+212%0.693+236%0.937+149%0.937+149%
Current Ratio--9.9364.639+114%4.067+144%6.098+63%6.098+63%
Debt To Asset Ratio--0.1310.841-84%0.432-70%0.549-76%0.549-76%
Debt To Equity Ratio--0.1510.534-72%1.215-88%0.720-79%0.720-79%
Dividend Per Share----0%-0%-0%-0%
Eps---0.886-0.521-41%-0.610-31%-0.507-43%-0.507-43%
Free Cash Flow Per Share---2.560-0.930-64%-0.525-80%-0.590-77%-0.590-77%
Free Cash Flow To Equity Per Share--0.8800.092+857%-0.076+109%0.007+12091%0.007+12091%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---133.397--------
Intrinsic Value_10Y_min---111.703--------
Intrinsic Value_1Y_max---4.267--------
Intrinsic Value_1Y_min---4.186--------
Intrinsic Value_3Y_max---19.757--------
Intrinsic Value_3Y_min---18.722--------
Intrinsic Value_5Y_max---43.608--------
Intrinsic Value_5Y_min---39.879--------
Market Cap290609880.000+40%173941680.000162593046.000+7%267011085.000-35%226959422.250-23%226959422.250-23%
Net Profit Margin----58.9390%-0%3115.285-100%3115.285-100%
Operating Margin----46.5860%-0%5977.323-100%5977.323-100%
Operating Ratio---46.586-100%-0%-6999.8570%-6999.8570%
Pb Ratio5.879+40%3.5194.375-20%39.860-91%15.282-77%15.282-77%
Pe Ratio-3.865-67%-2.314-4.299+86%-5.382+133%-5.905+155%-5.905+155%
Price Per Share13.700+40%8.2007.665+7%12.588-35%10.699-23%10.699-23%
Price To Free Cash Flow Ratio-1.338-67%-0.801-3.833+379%-6.929+765%-5.436+579%-5.436+579%
Price To Total Gains Ratio5.365+40%3.2110.163+1875%-17.673+650%-18.845+687%-18.845+687%
Quick Ratio--3.5442.994+18%4.010-12%5.747-38%5.747-38%
Return On Assets---0.330-1.033+213%-0.601+82%-0.618+87%-0.618+87%
Return On Equity---0.380-0.729+92%-1.541+305%-0.896+136%-0.896+136%
Total Gains Per Share--2.5540.501+410%-0.070+103%0.146+1653%0.146+1653%
Usd Book Value--4769802.0001527402.000+212%1419032.500+236%1917866.959+149%1917866.959+149%
Usd Book Value Change Per Share--0.2460.048+410%-0.007+103%0.014+1653%0.014+1653%
Usd Book Value Per Share--0.2250.072+212%0.067+236%0.090+149%0.090+149%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.086-0.050-41%-0.059-31%-0.049-43%-0.049-43%
Usd Free Cash Flow---5240529.000-1903462.500-64%-1073731.375-80%-1207534.656-77%-1207534.656-77%
Usd Free Cash Flow Per Share---0.247-0.090-64%-0.051-80%-0.057-77%-0.057-77%
Usd Free Cash Flow To Equity Per Share--0.0850.009+857%-0.007+109%0.001+12091%0.001+12091%
Usd Market Cap28043853.420+40%16785372.12015690228.939+7%25766569.703-35%21901584.247-23%21901584.247-23%
Usd Price Per Share1.322+40%0.7910.740+7%1.215-35%1.032-23%1.032-23%
Usd Profit---1813814.000-1065480.625-41%-1066252.625-41%-992277.311-45%-992277.311-45%
Usd Revenue---4053.000-100%-0%1024.124-100%1024.124-100%
Usd Total Gains Per Share--0.2460.048+410%-0.007+103%0.014+1653%0.014+1653%
 EOD+6 -2MRQTTM+21 -10YOY+17 -125Y+17 -1510Y+17 -15

3.3 Fundamental Score

Let's check the fundamental score of Lipum AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.865
Price to Book Ratio (EOD)Between0-15.879
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.544
Current Ratio (MRQ)Greater than19.936
Debt to Asset Ratio (MRQ)Less than10.131
Debt to Equity Ratio (MRQ)Less than10.151
Return on Equity (MRQ)Greater than0.15-0.380
Return on Assets (MRQ)Greater than0.05-0.330
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Lipum AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.495
Ma 20Greater thanMa 5012.805
Ma 50Greater thanMa 10012.558
Ma 100Greater thanMa 20010.299
OpenGreater thanClose13.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Lipum AB

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.

Fundamental data was last updated by Penke on 2024-09-23 07:34:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lipum earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lipum AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-5,893.9%+5,893.9%
TTM-5,893.9%YOY--5,893.9%
TTM-5,893.9%5Y311,528.5%-317,422.4%
5Y311,528.5%10Y311,528.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--124.5%+124.5%
TTM-5,893.9%-193.0%-5,700.9%
YOY--209.8%+209.8%
5Y311,528.5%-371.8%+311,900.3%
10Y311,528.5%-473.1%+312,001.6%
4.3.1.2. Return on Assets

Shows how efficient Lipum is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • -33.0% Return on Assets means that Lipum generated kr-0.33 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lipum AB:

  • The MRQ is -33.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -103.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.0%TTM-103.3%+70.3%
TTM-103.3%YOY-60.1%-43.2%
TTM-103.3%5Y-61.8%-41.6%
5Y-61.8%10Y-61.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.0%-10.9%-22.1%
TTM-103.3%-11.8%-91.5%
YOY-60.1%-11.2%-48.9%
5Y-61.8%-13.1%-48.7%
10Y-61.8%-14.8%-47.0%
4.3.1.3. Return on Equity

Shows how efficient Lipum is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • -38.0% Return on Equity means Lipum generated kr-0.38 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lipum AB:

  • The MRQ is -38.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -72.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.0%TTM-72.9%+34.9%
TTM-72.9%YOY-154.1%+81.1%
TTM-72.9%5Y-89.6%+16.7%
5Y-89.6%10Y-89.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.0%-14.2%-23.8%
TTM-72.9%-15.9%-57.0%
YOY-154.1%-13.7%-140.4%
5Y-89.6%-19.0%-70.6%
10Y-89.6%-19.5%-70.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Lipum AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lipum is operating .

  • Measures how much profit Lipum makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lipum AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4,658.6%+4,658.6%
TTM-4,658.6%YOY--4,658.6%
TTM-4,658.6%5Y597,732.3%-602,390.9%
5Y597,732.3%10Y597,732.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--276.1%+276.1%
TTM-4,658.6%-315.9%-4,342.7%
YOY--230.4%+230.4%
5Y597,732.3%-398.2%+598,130.5%
10Y597,732.3%-502.2%+598,234.5%
4.3.2.2. Operating Ratio

Measures how efficient Lipum is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Lipum AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM46.586-46.586
TTM46.586YOY-+46.586
TTM46.5865Y-6,999.857+7,046.442
5Y-6,999.85710Y-6,999.8570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.668-2.668
TTM46.5863.140+43.446
YOY-3.367-3.367
5Y-6,999.8575.133-7,004.990
10Y-6,999.8576.571-7,006.428
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Lipum AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lipum is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.94 means the company has kr9.94 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Lipum AB:

  • The MRQ is 9.936. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.639. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.936TTM4.639+5.297
TTM4.639YOY4.067+0.573
TTM4.6395Y6.098-1.459
5Y6.09810Y6.0980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9363.806+6.130
TTM4.6394.010+0.629
YOY4.0674.719-0.652
5Y6.0985.980+0.118
10Y6.0986.318-0.220
4.4.3.2. Quick Ratio

Measures if Lipum is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • A Quick Ratio of 3.54 means the company can pay off kr3.54 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lipum AB:

  • The MRQ is 3.544. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.994. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.544TTM2.994+0.550
TTM2.994YOY4.010-1.016
TTM2.9945Y5.747-2.754
5Y5.74710Y5.7470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5443.346+0.198
TTM2.9943.567-0.573
YOY4.0104.698-0.688
5Y5.7475.890-0.143
10Y5.7476.500-0.753
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Lipum AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lipum assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lipum to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Lipum assets are financed with 13.1% credit (debt) and the remaining percentage (100% - 13.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lipum AB:

  • The MRQ is 0.131. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.841. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.131TTM0.841-0.710
TTM0.841YOY0.432+0.410
TTM0.8415Y0.549+0.292
5Y0.54910Y0.5490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1310.340-0.209
TTM0.8410.344+0.497
YOY0.4320.309+0.123
5Y0.5490.365+0.184
10Y0.5490.384+0.165
4.5.4.2. Debt to Equity Ratio

Measures if Lipum is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • A Debt to Equity ratio of 15.1% means that company has kr0.15 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lipum AB:

  • The MRQ is 0.151. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.534. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.151TTM0.534-0.383
TTM0.534YOY1.215-0.681
TTM0.5345Y0.720-0.186
5Y0.72010Y0.7200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1510.392-0.241
TTM0.5340.436+0.098
YOY1.2150.371+0.844
5Y0.7200.446+0.274
10Y0.7200.489+0.231
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Lipum generates.

  • Above 15 is considered overpriced but always compare Lipum to the Biotechnology industry mean.
  • A PE ratio of -2.31 means the investor is paying kr-2.31 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lipum AB:

  • The EOD is -3.865. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.314. Based on the earnings, the company is expensive. -2
  • The TTM is -4.299. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.865MRQ-2.314-1.552
MRQ-2.314TTM-4.299+1.986
TTM-4.299YOY-5.382+1.083
TTM-4.2995Y-5.905+1.606
5Y-5.90510Y-5.9050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.865-2.299-1.566
MRQ-2.314-2.383+0.069
TTM-4.299-2.907-1.392
YOY-5.382-3.394-1.988
5Y-5.905-6.032+0.127
10Y-5.905-6.252+0.347
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lipum AB:

  • The EOD is -1.338. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.801. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.833. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.338MRQ-0.801-0.537
MRQ-0.801TTM-3.833+3.032
TTM-3.833YOY-6.929+3.095
TTM-3.8335Y-5.436+1.603
5Y-5.43610Y-5.4360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.338-2.936+1.598
MRQ-0.801-3.177+2.376
TTM-3.833-3.483-0.350
YOY-6.929-4.594-2.335
5Y-5.436-8.030+2.594
10Y-5.436-8.708+3.272
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lipum is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.52 means the investor is paying kr3.52 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Lipum AB:

  • The EOD is 5.879. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.519. Based on the equity, the company is fair priced.
  • The TTM is 4.375. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.879MRQ3.519+2.360
MRQ3.519TTM4.375-0.856
TTM4.375YOY39.860-35.485
TTM4.3755Y15.282-10.907
5Y15.28210Y15.2820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.8791.901+3.978
MRQ3.5191.970+1.549
TTM4.3752.197+2.178
YOY39.8602.362+37.498
5Y15.2823.574+11.708
10Y15.2824.203+11.079
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets56,898
Total Liabilities7,470
Total Stockholder Equity49,428
 As reported
Total Liabilities 7,470
Total Stockholder Equity+ 49,428
Total Assets = 56,898

Assets

Total Assets56,898
Total Current Assets56,726
Long-term Assets172
Total Current Assets
Cash And Cash Equivalents 20,131
Net Receivables 100
Total Current Assets  (as reported)56,726
Total Current Assets  (calculated)20,231
+/- 36,495
Long-term Assets
Property Plant Equipment 172
Long-term Assets  (as reported)172
Long-term Assets  (calculated)172
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,709
Long-term Liabilities1,761
Total Stockholder Equity49,428
Total Current Liabilities
Accounts payable 3,592
Other Current Liabilities 2,117
Total Current Liabilities  (as reported)5,709
Total Current Liabilities  (calculated)5,709
+/-0
Long-term Liabilities
Long term Debt 1,761
Long-term Liabilities  (as reported)1,761
Long-term Liabilities  (calculated)1,761
+/-0
Total Stockholder Equity
Common Stock5,303
Retained Earnings -191,639
Other Stockholders Equity 235,764
Total Stockholder Equity (as reported)49,428
Total Stockholder Equity (calculated)49,428
+/-0
Other
Capital Stock5,303
Cash and Short Term Investments 20,131
Common Stock Shares Outstanding 17,247
Liabilities and Stockholders Equity 56,898
Net Debt -18,370
Net Invested Capital 51,189
Net Working Capital 51,017
Property Plant and Equipment Gross 172
Short Long Term Debt Total 1,761



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
15,137
10,088
6,036
70,795
62,471
49,662
31,015
22,906
12,548
34,551
28,268
14,237
18,785
12,110
3,487
56,898
56,8983,48712,11018,78514,23728,26834,55112,54822,90631,01549,66262,47170,7956,03610,08815,137
   > Total Current Assets 
15,137
10,088
4,982
70,795
62,471
48,102
29,268
21,038
10,556
34,502
28,222
14,015
18,576
11,913
3,303
56,726
56,7263,30311,91318,57614,01528,22234,50210,55621,03829,26848,10262,47170,7954,98210,08815,137
       Cash And Cash Equivalents 
14,806
4,440
4,165
68,730
61,941
47,053
27,971
18,783
9,482
32,837
26,765
12,364
17,551
10,226
1,473
20,131
20,1311,47310,22617,55112,36426,76532,8379,48218,78327,97147,05361,94168,7304,1654,44014,806
       Short-term Investments 
0
0
8,880
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000008,88000
       Net Receivables 
313
5,648
817
2,035
499
914
1,205
1,378
816
1,422
1,219
1,124
812
1,313
1,461
100
1001,4611,3138121,1241,2191,4228161,3781,2059144992,0358175,648313
       Other Current Assets 
18
0
0
2,065
530
1,049
1,297
2,255
1,074
243
238
1,651
213
374
369
0
03693742131,6512382431,0742,2551,2971,0495302,0650018
   > Long-term Assets 
0
1,054
1,054
0
0
1,560
1,747
1,868
1,992
49
46
222
209
197
184
172
17218419720922246491,9921,8681,7471,560001,0541,0540
       Property Plant Equipment 
0
0
0
0
0
0
60
55
52
49
46
222
209
197
184
172
1721841972092224649525560000000
       Other Assets 
0
-1,054
0
0
0
1,560
1,687
1,813
1,940
0
0
0
0
0
0
0
00000001,9401,8131,6871,560000-1,0540
> Total Liabilities 
2,691
6,861
8,918
7,712
5,415
21,781
8,845
10,031
9,574
6,504
7,394
7,312
4,732
7,538
8,228
7,470
7,4708,2287,5384,7327,3127,3946,5049,57410,0318,84521,7815,4157,7128,9186,8612,691
   > Total Current Liabilities 
691
5,385
6,388
6,236
3,939
18,655
5,592
6,652
6,068
4,843
5,733
5,651
3,071
5,777
6,467
5,709
5,7096,4675,7773,0715,6515,7334,8436,0686,6525,59218,6553,9396,2366,3885,385691
       Accounts payable 
455
653
945
1,264
865
1,375
2,196
3,481
1,650
944
2,308
2,609
1,712
4,100
5,514
3,592
3,5925,5144,1001,7122,6092,3089441,6503,4812,1961,3758651,264945653455
       Other Current Liabilities 
236
4,732
5,443
4,972
3,074
17,280
3,396
3,171
4,418
3,899
3,425
3,042
1,359
1,677
953
2,117
2,1179531,6771,3593,0423,4253,8994,4183,1713,39617,2803,0744,9725,4434,732236
   > Long-term Liabilities 
2,000
1,476
2,530
1,476
1,476
3,126
3,253
3,379
3,506
1,661
1,661
1,661
1,661
1,761
1,761
1,761
1,7611,7611,7611,6611,6611,6611,6613,5063,3793,2533,1261,4761,4762,5301,4762,000
       Other Liabilities 
0
1,054
0
0
0
1,560
1,687
1,813
1,940
0
0
0
0
0
0
0
00000001,9401,8131,6871,5600001,0540
> Total Stockholder Equity
12,446
3,227
-2,882
63,083
57,056
27,881
22,170
12,875
2,974
28,047
20,874
6,925
14,053
4,572
-4,741
49,428
49,428-4,7414,57214,0536,92520,87428,0472,97412,87522,17027,88157,05663,083-2,8823,22712,446
   Common Stock
236
236
589
1,263
1,263
1,263
1,263
1,263
1,263
1,914
1,914
1,914
2,329
2,329
2,329
5,303
5,3032,3292,3292,3291,9141,9141,9141,2631,2631,2631,2631,2631,263589236236
   Retained Earnings -191,639-172,843-163,530-154,079-147,474-133,525-126,352-113,335-103,434-94,139-88,428-59,253-53,630-42,281-35,819-26,054
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
38,264
38,810
35,583
115,450
115,046
115,046
115,046
115,046
115,046
152,485
152,485
152,485
165,803
165,773
165,773
235,764
235,764165,773165,773165,803152,485152,485152,485115,046115,046115,046115,046115,046115,45035,58338,81038,264



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue53
Cost of Revenue-40
Gross Profit1313
 
Operating Income (+$)
Gross Profit13
Operating Expense-32,586
Operating Income-32,626-32,573
 
Operating Expense (+$)
Research Development26,001
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense32,58626,001
 
Net Interest Income (+$)
Interest Income99
Interest Expense-212
Other Finance Cost-0
Net Interest Income-113
 
Pretax Income (+$)
Operating Income-32,626
Net Interest Income-113
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-37,178-28,074
EBIT - interestExpense = -32,838
-37,178
-36,966
Interest Expense212
Earnings Before Interest and Taxes (EBIT)-32,626-36,966
Earnings Before Interest and Taxes (EBITDA)-32,586
 
After tax Income (+$)
Income Before Tax-37,178
Tax Provision-0
Net Income From Continuing Ops-40,744-37,178
Net Income-37,178
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,626
Total Other Income/Expenses Net-4,552113
 

Technical Analysis of Lipum
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lipum. The general trend of Lipum is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lipum's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lipum AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 14.25 < 14.25 < 14.25.

The bearish price targets are: 12.90 > 11.50 > 11.30.

Tweet this
Lipum AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lipum AB. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lipum AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lipum AB. The current macd is 0.37862138.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lipum price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lipum. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lipum price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lipum AB Daily Moving Average Convergence/Divergence (MACD) ChartLipum AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lipum AB. The current adx is 32.34.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lipum shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Lipum AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lipum AB. The current sar is 11.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Lipum AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lipum AB. The current rsi is 59.49. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Lipum AB Daily Relative Strength Index (RSI) ChartLipum AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lipum AB. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lipum price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lipum AB Daily Stochastic Oscillator ChartLipum AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lipum AB. The current cci is 92.34.

Lipum AB Daily Commodity Channel Index (CCI) ChartLipum AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lipum AB. The current cmo is 22.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Lipum AB Daily Chande Momentum Oscillator (CMO) ChartLipum AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lipum AB. The current willr is -35.29411765.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lipum is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lipum AB Daily Williams %R ChartLipum AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lipum AB.

Lipum AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lipum AB. The current atr is 0.86897191.

Lipum AB Daily Average True Range (ATR) ChartLipum AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lipum AB. The current obv is 180,434.

Lipum AB Daily On-Balance Volume (OBV) ChartLipum AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lipum AB. The current mfi is 67.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lipum AB Daily Money Flow Index (MFI) ChartLipum AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lipum AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-06-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lipum AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lipum AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.495
Ma 20Greater thanMa 5012.805
Ma 50Greater thanMa 10012.558
Ma 100Greater thanMa 20010.299
OpenGreater thanClose13.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lipum with someone you think should read this too:
  • Are you bullish or bearish on Lipum? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lipum? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lipum AB

I send you an email if I find something interesting about Lipum AB.


Comments

How you think about this?

Leave a comment

Stay informed about Lipum AB.

Receive notifications about Lipum AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.